| Target Professions: | DO, MD, Nurse Practitioner, Physician Associate/Assistant |
| Target Specialties: | Allergy and Immunology, Gastroenterology, Family Medicine, Pediatric Gastroenterology, Pediatrics, Pharmacy |
| Credits Available: | 5.00 hours of AMA PRA Category 1 Credit™ with ABIM MOC |
This curriculum provides practical guidance on the diagnosis and management of eosinophilic esophagitis (EoE), a chronic, immune-mediated disease of the esophagus with rising prevalence. Learners will engage with current diagnostic algorithms, examine treatment options including dietary therapy, topical corticosteroids, and biologics, and explore strategies to meet payer documentation requirements for timely access to care. Designed for gastroenterologists, allergists, and other clinicians involved in the care of patients with EoE, the program emphasizes accurate diagnosis, coordinated multidisciplinary care, and personalized, evidence-based treatment planning.
Please answer a few questions to assess your current knowledge of EoE mechanisms, diagnostic criteria, treatment options, and payer-related documentation requirements.
This module discusses how to apply guideline-based criteria for diagnosing EoE, including symptoms, endoscopy, biopsies, and differentiation from GERD and other conditions, to support timely treatment access and reduce diagnostic delays.
Explore evolving treatments for EoE, from PPIs and topical steroids to dietary strategies, biologics, and dilation. Learn how to personalize therapy, reduce patient burden, and integrate shared decision-making to optimize outcomes.
This module discusses how to meet payer requirements for biologic approval in EoE through accurate documentation, ICD-10 coding, and step therapy records, while applying strategies to minimize denials and ensure timely patient access.
Examine how coordinated, multidisciplinary care in EoE—linking GI, allergy, nutrition, pathology, and behavioral health—can streamline workflows, reduce access barriers, and improve outcomes through shared documentation and communication.
Now that you’ve completed the modules, please complete this brief final assessment on EoE pathophysiology, diagnosis, treatment selection, and documentation strategies to support payer approval and timely access to care.
Explore evolving strategies in EoE, from guideline-based diagnosis and treatment sequencing to reducing delays, improving documentation for payer approval, and supporting patient-centered care to ease clinical, psychosocial, and financial burden.
Liam is a 10-year-old patient with abdominal pain, poor growth, and feeding difficulties despite PPI therapy. Endoscopy shows mild furrows; biopsies reveal 8 eos/hpf with limited sampling.
Marissa, 34, had a two-year delay before EoE was confirmed with 22–26 eos/hpf. A PA for dupilumab was denied for missing documentation. She is frustrated and confused about food allergy, diet, and payer delays in treatment.
After completing this program, select areas you will change in your practice to improve care for patients with EoE.
Examine diagnostic reasoning in complex EoE cases, with insights from multidisciplinary coordination, patient and caregiver engagement, and payer documentation—using case-based learning to highlight practical strategies for improved outcomes.
